These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8748888)

  • 21. [New ways of studying the cutaneous microcirculation in clinical medicine (author's transl)].
    Bollinger A; Jäger K
    Arzneimittelforschung; 1981; 31(11a):2015-9. PubMed ID: 7199291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vital capillaroscopy on microcirculation: pharmacodynamic activity of Daflon 500 mg in venous insufficiency.
    Balas P; Pagratis N
    Int Angiol; 1989; 8(4 Suppl):51-2. PubMed ID: 2632650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The drug therapy of chronic venous insufficiency (a trial of the clinical use of the preparation Detralex)].
    Iablokov EG; Bogachev VIu; Domoradskaia AI
    Ter Arkh; 1996; 68(10):80-1. PubMed ID: 9026954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skin microvascular architecture and perfusion studied in human postmastectomy oedema by intravital video-capillaroscopy.
    Roberts CC; Stanton AW; Pullen J; Bull RH; Levick JR; Mortimer PS
    Int J Microcirc Clin Exp; 1994; 14(6):327-34. PubMed ID: 7543461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From symptoms to leg edema: efficacy of Daflon 500 mg.
    Nicolaides AN
    Angiology; 2003; 54 Suppl 1():S33-44. PubMed ID: 12934755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vital microscopy and the pathophysiology of deep venous insufficiency.
    Fagrell B
    Int Angiol; 1995 Sep; 14(3 Suppl 1):18-22. PubMed ID: 8919259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical benefits of Daflon 500 mg in the most severe stages of chronic venous insufficiency.
    Ramelet AA
    Angiology; 2001 Aug; 52 Suppl 1():S49-56. PubMed ID: 11510597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular basis of inflammation, edema and the activity of Daflon 500 mg.
    Friesenecker B; Tsai AG; Intaglietta M
    Int J Microcirc Clin Exp; 1995; 15 Suppl 1():17-21. PubMed ID: 8748884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorescence microlymphography in chronic venous incompetence.
    Bollinger A; Pfister G; Hoffmann U; Franzeck UK
    Int Angiol; 1989; 8(4 Suppl):23-6. PubMed ID: 2483727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in microcirculation network evaluation: an update.
    Fagrell B
    Int J Microcirc Clin Exp; 1995; 15 Suppl 1():34-40. PubMed ID: 8748887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Micromorphologic changes in the skin in primary and secondary (post-thrombotic) chronic venous insufficiency].
    Leu HJ
    Wien Med Wochenschr; 1994; 144(10-11):201-4. PubMed ID: 7856184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. At the crossroads of venous insufficiency and hemorrhoidal disease: Daflon 500 mg--repercussions of venous insufficiency on everyday life.
    Launois R
    Angiology; 1994 Jun; 45(6 Pt 2):495-504. PubMed ID: 8203779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and security of Daflon 500 mg in venous insufficiency and in hemorrhoidal disease.
    Meyer OC
    Angiology; 1994 Jun; 45(6 Pt 2):579-84. PubMed ID: 8203791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The principles of action and use of phlebotropic agents].
    Kharkevich DA
    Klin Med (Mosk); 2004; 82(11):4-10. PubMed ID: 15656390
    [No Abstract]   [Full Text] [Related]  

  • 35. [Imaging of cutaneous blood and lymph capillaries by video microscopy with and without fluorescent dyes].
    Bollinger A; Franzeck UK; Hoffmann U
    Internist (Berl); 1994 Jun; 35(6):557-63. PubMed ID: 8071028
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of Daflon 500 mg on increased microvascular permeability in normal hamsters.
    Bouskela E; Donyo KA; Verbeuren TJ
    Int J Microcirc Clin Exp; 1995; 15 Suppl 1():22-6. PubMed ID: 8748885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic aspects of a phlebotropic drug in CVI-associated edema.
    Ramelet AA
    Angiology; 2000 Jan; 51(1):19-23. PubMed ID: 10667639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcapillary and interstitial diffusion of Na-fluorescein in chronic venous insufficiency with white atrophy.
    Bollinger A; Jäger K; Geser A; Sgier F; Seglias J
    Int J Microcirc Clin Exp; 1982; 1(1):5-17. PubMed ID: 7188441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HR (Venoruton1000, Paroven, 0-[beta-hydroxyethyl]-rutosides) vs. Daflon 500 in chronic venous disease and microangiopathy: an independent prospective, controlled, randomized trial.
    Belcaro G; Cesarone MR; Bavera P; Ricci A; Renton S; Leon M; Ippolito E; Dugall M; Acerbi G
    J Cardiovasc Pharmacol Ther; 2002 Jul; 7(3):139-45. PubMed ID: 12232562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of compression therapy on the microcirculation of the skin in patients with chronic venous insufficiency (CVI)].
    Klyscz T; Galler S; Steins A; Züder D; Rassner G; Jünger M
    Hautarzt; 1997 Nov; 48(11):806-11. PubMed ID: 9518241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.